---
title: "萊佛士醫療集團回購了更多股份"
description: "萊佛士醫療集團在新加坡證券交易所當天發佈的文件中表示，週三以 SG$199,260 回購了 200,000 股，平均每股 SG$0.995。該醫療服務提供商目前已在其現有授權下回購了 510 萬股"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/232541003.md"
published_at: "2025-03-20T08:20:39.000Z"
---

# 萊佛士醫療集團回購了更多股份

> 萊佛士醫療集團在新加坡證券交易所當天發佈的文件中表示，週三以 SG$199,260 回購了 200,000 股，平均每股 SG$0.995。該醫療服務提供商目前已在其現有授權下回購了 510 萬股

根據新加坡證券交易所當天的公告，萊佛士醫療集團在週三以 199,260 新元的價格回購了 200,000 股，單價為 0.995 新元。

該醫療服務提供商目前已根據其現有授權回購了 510 萬股。

### Related Stocks

- [BSL.SG - 萊佛士醫療](https://longbridge.com/zh-HK/quote/BSL.SG.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Raffles Medical Group: Solid Balance Sheet and Earnings Inflection Underscore Attractive Entry Point | Analyst Wee Kuang Tay of CGS-CIMB has reiterated a Buy rating on Raffles Medical Group with a price target of S$1.23, ci | [Link](https://longbridge.com/zh-HK/news/271645484.md) |
| AgelessRx Expands Access to Multi-Cancer Early Detection Solutions, in Honor of Cancer Prevention Month | AgelessRx is expanding access to its multi-cancer early detection solutions in honor of Cancer Prevention Month. This in | [Link](https://longbridge.com/zh-HK/news/276180967.md) |
| Xsolis Announces the Appointment of Vic Pierni as Chief Financial Officer | Xsolis has appointed Vic Pierni as Chief Financial Officer. Pierni, a CPA with over 25 years of experience in financial  | [Link](https://longbridge.com/zh-HK/news/276187646.md) |
| Physitrack Intends To Implement Share Buyback Program | Physitrack PLC :BOARD APPROVES INTENTION TO IMPLEMENT SHARE BUYBACK PROGRAMTO REPURCHASE UP TO 10% OF ISSUED SHARE CAPIT | [Link](https://longbridge.com/zh-HK/news/276423338.md) |
| ZAWYA-PRESSR: Frimex acquires 60% stake in Gulf Neo Care to establish a strategic healthcare platform in Saudi Arabia | Frimex International Investment Company has acquired a 60% stake in Gulf Neo Care, a Saudi firm specializing in neonatal | [Link](https://longbridge.com/zh-HK/news/276105068.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。